Swallowing difficulties pose great risks for Duopa-treated patients
Dysphagia, or swallowing difficulties, is associated with a higher risk of death among people with advanced Parkinson’s disease who…
Articles by Patricia Valerio, PhD
Fosgonimeton trial in Parkinson’s dementia to have fewer participants
Athira Pharma is completing its Phase 2 clinical trial of the experimental therapy fosgonimeton in people with Parkinson’s…
Parkinson’s preclinical research on dapansutrile awarded grant
Olatec Therapeutics has been awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to further…
Strong link between Parkinson’s, certain autoimmune diseases: Study
People with Parkinson’s disease are at a higher risk of simultaneous autoimmune diseases where the immune system erroneously attacks…
Parkinson’s Medicines Not Much Help in Severe Abdominal Pain
Medicines for Parkinson’s disease in patients with persistent intolerable abdominal pain showed short…
IRL1117, Potential Improvement on Levodopa, May Enter Clinical Trial
IRLAB Therapeutics has selected a dopamine receptor agonist candidate called IRL1117 to advance as a Parkinson’s disease treatment, potentially…
Higher Risk of Parkinson’s Linked to Lower Total, ‘Bad’ Cholesterol
Lower blood levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, are significantly associated with a higher…